John Alexander Kelly - 02 Nov 2024 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Financial Officer
Signature: /s/ Dario Scimeca, Attorney-in-fact for John Alexander Kelly
Issuer symbol: DTIL
Transactions as of: 02 Nov 2024
Net transactions value: $0
Form type: 4
Filing time: 05 Nov 2024, 19:14:42 UTC
Previous filing: 23 Aug 2024
Next filing: 21 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Options Exercise		+3,605	+11%		35,073	02 Nov 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Restricted Stock Units	Options Exercise	$0	-3,605	-50%	$0.000000	3,605	02 Nov 2024	Common Stock	3,605		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2024.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3	On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.